| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Reproductive Techniques, Assisted | 11 | 2021 | 78 | 1.790 |
Why?
|
| Polycystic Ovary Syndrome | 6 | 2023 | 67 | 1.220 |
Why?
|
| Infertility | 5 | 2019 | 74 | 1.090 |
Why?
|
| Fertilization in Vitro | 10 | 2022 | 150 | 1.060 |
Why?
|
| Endometriosis | 3 | 2022 | 163 | 0.860 |
Why?
|
| Infertility, Female | 3 | 2023 | 147 | 0.860 |
Why?
|
| Abortion, Spontaneous | 2 | 2022 | 81 | 0.800 |
Why?
|
| Anti-Mullerian Hormone | 3 | 2023 | 40 | 0.800 |
Why?
|
| Ovarian Reserve | 1 | 2023 | 12 | 0.780 |
Why?
|
| Progestins | 2 | 2019 | 40 | 0.630 |
Why?
|
| Endometrium | 6 | 2019 | 292 | 0.630 |
Why?
|
| Decidua | 6 | 2019 | 144 | 0.610 |
Why?
|
| Luteal Phase | 1 | 2019 | 8 | 0.610 |
Why?
|
| Pregnancy, Multiple | 5 | 2015 | 43 | 0.580 |
Why?
|
| Embryo Transfer | 6 | 2022 | 48 | 0.530 |
Why?
|
| Live Birth | 5 | 2022 | 69 | 0.530 |
Why?
|
| Societies, Medical | 6 | 2019 | 798 | 0.520 |
Why?
|
| Stromal Cells | 7 | 2019 | 316 | 0.520 |
Why?
|
| Oocytes | 5 | 2022 | 282 | 0.490 |
Why?
|
| Reproductive Medicine | 2 | 2019 | 19 | 0.460 |
Why?
|
| Fertility | 5 | 2022 | 260 | 0.450 |
Why?
|
| Quality Indicators, Health Care | 2 | 2019 | 237 | 0.420 |
Why?
|
| Pregnancy | 23 | 2022 | 7387 | 0.420 |
Why?
|
| Ovulation Induction | 3 | 2021 | 38 | 0.380 |
Why?
|
| Uterus | 3 | 2017 | 545 | 0.370 |
Why?
|
| Embryo Implantation | 5 | 2022 | 219 | 0.360 |
Why?
|
| Risk Management | 1 | 2012 | 66 | 0.350 |
Why?
|
| Receptors, Progesterone | 5 | 2021 | 679 | 0.350 |
Why?
|
| Laboratories | 1 | 2012 | 79 | 0.350 |
Why?
|
| Female | 43 | 2023 | 70325 | 0.340 |
Why?
|
| Pregnancy Rate | 5 | 2022 | 39 | 0.340 |
Why?
|
| Medical Errors | 1 | 2012 | 145 | 0.330 |
Why?
|
| Body Mass Index | 1 | 2015 | 1675 | 0.290 |
Why?
|
| Pregnancy Outcome | 2 | 2016 | 611 | 0.280 |
Why?
|
| Spermatozoa | 1 | 2010 | 254 | 0.280 |
Why?
|
| Ovary | 2 | 2021 | 347 | 0.280 |
Why?
|
| Immunoassay | 2 | 2021 | 126 | 0.270 |
Why?
|
| Biomarkers | 2 | 2016 | 3381 | 0.250 |
Why?
|
| Gene Expression Regulation | 6 | 2021 | 2334 | 0.240 |
Why?
|
| Humans | 42 | 2023 | 130376 | 0.230 |
Why?
|
| Practice Guidelines as Topic | 2 | 2009 | 1287 | 0.230 |
Why?
|
| Nuclear Receptor Coactivator 2 | 2 | 2018 | 148 | 0.230 |
Why?
|
| Transcriptome | 5 | 2021 | 1113 | 0.220 |
Why?
|
| Obesity | 2 | 2020 | 2382 | 0.220 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2017 | 369 | 0.220 |
Why?
|
| Follicle Stimulating Hormone | 3 | 2023 | 176 | 0.210 |
Why?
|
| Ovarian Diseases | 1 | 2004 | 23 | 0.210 |
Why?
|
| Quality of Health Care | 1 | 2007 | 408 | 0.210 |
Why?
|
| Retrospective Studies | 13 | 2022 | 17502 | 0.200 |
Why?
|
| Receptors, FSH | 1 | 2023 | 18 | 0.200 |
Why?
|
| Androgens | 2 | 2022 | 246 | 0.180 |
Why?
|
| Hyperandrogenism | 1 | 2022 | 19 | 0.180 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2017 | 968 | 0.170 |
Why?
|
| Early Growth Response Protein 1 | 2 | 2019 | 38 | 0.170 |
Why?
|
| Adult | 18 | 2021 | 31095 | 0.170 |
Why?
|
| Uterine Contraction | 1 | 2021 | 28 | 0.170 |
Why?
|
| Receptors, Oxytocin | 1 | 2021 | 21 | 0.170 |
Why?
|
| TRPC Cation Channels | 1 | 2021 | 20 | 0.170 |
Why?
|
| Promyelocytic Leukemia Zinc Finger Protein | 2 | 2018 | 12 | 0.170 |
Why?
|
| Biological Products | 1 | 2022 | 143 | 0.160 |
Why?
|
| Preimplantation Diagnosis | 1 | 2020 | 26 | 0.160 |
Why?
|
| Multiple Birth Offspring | 3 | 2015 | 6 | 0.160 |
Why?
|
| Anniversaries and Special Events | 1 | 2019 | 9 | 0.150 |
Why?
|
| Placenta Previa | 1 | 2020 | 66 | 0.150 |
Why?
|
| Fetal Development | 1 | 2021 | 121 | 0.150 |
Why?
|
| Pregnancy, Twin | 1 | 2021 | 191 | 0.150 |
Why?
|
| Embryo, Mammalian | 2 | 2011 | 403 | 0.140 |
Why?
|
| Diet, Protein-Restricted | 1 | 2019 | 71 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2021 | 585 | 0.140 |
Why?
|
| Cryopreservation | 2 | 2012 | 78 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2017 | 11 | 0.130 |
Why?
|
| WNK Lysine-Deficient Protein Kinase 1 | 1 | 2017 | 15 | 0.130 |
Why?
|
| Vaccination | 1 | 2023 | 1051 | 0.130 |
Why?
|
| Placenta Accreta | 1 | 2020 | 172 | 0.130 |
Why?
|
| Pregnancy, Animal | 1 | 2017 | 66 | 0.130 |
Why?
|
| Cells, Cultured | 6 | 2019 | 2895 | 0.130 |
Why?
|
| Insulin Resistance | 1 | 2022 | 687 | 0.130 |
Why?
|
| Leiomyoma | 1 | 2017 | 71 | 0.130 |
Why?
|
| Mitochondria | 2 | 2020 | 774 | 0.130 |
Why?
|
| Cancer Care Facilities | 1 | 2016 | 32 | 0.120 |
Why?
|
| Folic Acid | 1 | 2019 | 269 | 0.120 |
Why?
|
| Cesarean Section | 1 | 2020 | 422 | 0.120 |
Why?
|
| United States | 9 | 2019 | 11868 | 0.120 |
Why?
|
| Follicular Fluid | 1 | 2016 | 6 | 0.120 |
Why?
|
| Luteal Cells | 1 | 2016 | 8 | 0.120 |
Why?
|
| Uterine Neoplasms | 1 | 2017 | 100 | 0.120 |
Why?
|
| Amino Acids | 1 | 2019 | 561 | 0.120 |
Why?
|
| Cell Proliferation | 4 | 2018 | 2464 | 0.120 |
Why?
|
| Fertility Preservation | 1 | 2016 | 61 | 0.120 |
Why?
|
| Dietary Supplements | 1 | 2019 | 449 | 0.120 |
Why?
|
| Prenatal Diagnosis | 1 | 2020 | 609 | 0.120 |
Why?
|
| Progesterone | 1 | 2017 | 440 | 0.110 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2016 | 109 | 0.110 |
Why?
|
| Choice Behavior | 1 | 2016 | 139 | 0.110 |
Why?
|
| Single Embryo Transfer | 1 | 2015 | 2 | 0.110 |
Why?
|
| Interferon Regulatory Factors | 1 | 2015 | 45 | 0.110 |
Why?
|
| Cleavage Stage, Ovum | 2 | 2011 | 4 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2017 | 599 | 0.100 |
Why?
|
| Phosphofructokinase-2 | 1 | 2013 | 23 | 0.100 |
Why?
|
| Transcription, Genetic | 2 | 2016 | 1367 | 0.100 |
Why?
|
| Genetic Testing | 1 | 2020 | 1102 | 0.100 |
Why?
|
| Referral and Consultation | 1 | 2016 | 552 | 0.090 |
Why?
|
| Quality Improvement | 1 | 2019 | 710 | 0.090 |
Why?
|
| Follicular Phase | 2 | 2019 | 10 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 373 | 0.090 |
Why?
|
| Databases as Topic | 1 | 2012 | 73 | 0.090 |
Why?
|
| Registries | 1 | 2019 | 1611 | 0.090 |
Why?
|
| Models, Statistical | 1 | 2014 | 482 | 0.090 |
Why?
|
| Blastomeres | 1 | 2011 | 6 | 0.090 |
Why?
|
| Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2010 | 2 | 0.080 |
Why?
|
| Editorial Policies | 1 | 2011 | 50 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2018 | 1591 | 0.080 |
Why?
|
| Cooperative Behavior | 1 | 2012 | 222 | 0.080 |
Why?
|
| Health Services Accessibility | 1 | 2016 | 693 | 0.080 |
Why?
|
| Comprehension | 1 | 2010 | 80 | 0.080 |
Why?
|
| Practice Management | 1 | 2009 | 5 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 2012 | 0.080 |
Why?
|
| Animals | 9 | 2022 | 33846 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 5159 | 0.080 |
Why?
|
| Informed Consent | 1 | 2012 | 350 | 0.070 |
Why?
|
| Birth Weight | 1 | 2010 | 343 | 0.070 |
Why?
|
| Cytokines | 3 | 2022 | 1343 | 0.070 |
Why?
|
| Prognosis | 2 | 2015 | 4862 | 0.070 |
Why?
|
| Age Factors | 1 | 2015 | 2829 | 0.070 |
Why?
|
| Inflammation | 1 | 2016 | 1483 | 0.070 |
Why?
|
| Periodicals as Topic | 1 | 2011 | 182 | 0.070 |
Why?
|
| Infant, Newborn | 4 | 2021 | 8528 | 0.070 |
Why?
|
| Mice | 6 | 2022 | 18219 | 0.070 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2020 | 774 | 0.070 |
Why?
|
| Annual Reports as Topic | 1 | 2007 | 2 | 0.070 |
Why?
|
| Communication | 1 | 2012 | 540 | 0.070 |
Why?
|
| Embryo Culture Techniques | 1 | 2007 | 19 | 0.070 |
Why?
|
| Oocyte Donation | 1 | 2007 | 5 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 382 | 0.060 |
Why?
|
| Time Factors | 2 | 2019 | 6196 | 0.060 |
Why?
|
| Gestational Age | 1 | 2010 | 1206 | 0.060 |
Why?
|
| Male | 7 | 2022 | 64453 | 0.060 |
Why?
|
| Program Development | 1 | 2007 | 182 | 0.060 |
Why?
|
| Insurance, Health | 1 | 2007 | 140 | 0.060 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 3795 | 0.060 |
Why?
|
| Insurance Coverage | 1 | 2007 | 116 | 0.060 |
Why?
|
| Risk Factors | 3 | 2020 | 10946 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2011 | 1223 | 0.060 |
Why?
|
| Cell Differentiation | 1 | 2013 | 1921 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 3 | 2022 | 4714 | 0.060 |
Why?
|
| Leuprolide | 1 | 2005 | 17 | 0.050 |
Why?
|
| Luteinizing Hormone | 1 | 2005 | 119 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2017 | 525 | 0.050 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2015 | 223 | 0.050 |
Why?
|
| RNA, Small Interfering | 2 | 2017 | 665 | 0.050 |
Why?
|
| Cell Movement | 2 | 2018 | 870 | 0.050 |
Why?
|
| Patient Education as Topic | 1 | 2007 | 461 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 2 | 2018 | 411 | 0.050 |
Why?
|
| Follicle Stimulating Hormone, Human | 1 | 2023 | 5 | 0.050 |
Why?
|
| Aromatase | 1 | 2023 | 23 | 0.050 |
Why?
|
| Embryo Research | 1 | 2003 | 8 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2019 | 12836 | 0.050 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2023 | 82 | 0.050 |
Why?
|
| Iridoid Glucosides | 1 | 2022 | 5 | 0.050 |
Why?
|
| Gonadotropins | 1 | 2002 | 31 | 0.050 |
Why?
|
| Clomiphene | 1 | 2002 | 15 | 0.050 |
Why?
|
| Granulosa Cells | 1 | 2023 | 140 | 0.050 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2002 | 67 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2012 | 3671 | 0.050 |
Why?
|
| Estrogen Receptor beta | 1 | 2022 | 79 | 0.050 |
Why?
|
| Organ Preservation | 1 | 2003 | 62 | 0.050 |
Why?
|
| Delivery, Obstetric | 1 | 2005 | 257 | 0.050 |
Why?
|
| Neoplasms | 1 | 2016 | 2966 | 0.040 |
Why?
|
| Ovarian Hyperstimulation Syndrome | 1 | 2021 | 12 | 0.040 |
Why?
|
| Fertilization | 1 | 2021 | 44 | 0.040 |
Why?
|
| Sex Differentiation | 1 | 2021 | 18 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2017 | 2551 | 0.040 |
Why?
|
| Mice, Obese | 1 | 2020 | 74 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2007 | 914 | 0.040 |
Why?
|
| Cell Shape | 2 | 2011 | 68 | 0.040 |
Why?
|
| Parturition | 1 | 2021 | 66 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2021 | 355 | 0.040 |
Why?
|
| Ovarian Follicle | 1 | 2021 | 121 | 0.040 |
Why?
|
| Estrogens | 1 | 2022 | 429 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 1807 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2020 | 267 | 0.040 |
Why?
|
| Pregnancy Trimester, First | 1 | 2020 | 115 | 0.040 |
Why?
|
| Aneuploidy | 1 | 2020 | 136 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2020 | 231 | 0.040 |
Why?
|
| ROC Curve | 1 | 2021 | 610 | 0.040 |
Why?
|
| Cumulus Cells | 1 | 2019 | 42 | 0.040 |
Why?
|
| Cell Count | 2 | 2011 | 214 | 0.040 |
Why?
|
| Vitamin B Complex | 1 | 2019 | 36 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2019 | 131 | 0.040 |
Why?
|
| Young Adult | 3 | 2020 | 9979 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 319 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2019 | 301 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2019 | 257 | 0.030 |
Why?
|
| Role | 1 | 2017 | 27 | 0.030 |
Why?
|
| Data Collection | 2 | 2011 | 370 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2019 | 363 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2019 | 416 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2020 | 1209 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 204 | 0.030 |
Why?
|
| Kinetics | 1 | 2019 | 1084 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 1376 | 0.030 |
Why?
|
| Reproductive Health Services | 1 | 2016 | 23 | 0.030 |
Why?
|
| Genital Neoplasms, Female | 1 | 2016 | 43 | 0.030 |
Why?
|
| RNA Interference | 1 | 2018 | 493 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2017 | 171 | 0.030 |
Why?
|
| Chemokines | 1 | 2016 | 126 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2017 | 1016 | 0.030 |
Why?
|
| Fos-Related Antigen-2 | 1 | 2015 | 4 | 0.030 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2015 | 20 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 644 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2017 | 201 | 0.030 |
Why?
|
| Nucleotide Motifs | 1 | 2015 | 51 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2017 | 452 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2015 | 99 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 2015 | 110 | 0.030 |
Why?
|
| Validation Studies as Topic | 1 | 2014 | 12 | 0.030 |
Why?
|
| Gene Expression | 1 | 2019 | 1486 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 539 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 1595 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 1210 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 1206 | 0.030 |
Why?
|
| Hematologic Neoplasms | 1 | 2016 | 312 | 0.020 |
Why?
|
| Computational Biology | 1 | 2018 | 862 | 0.020 |
Why?
|
| Binding Sites | 1 | 2015 | 1136 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 292 | 0.020 |
Why?
|
| Retirement | 1 | 2011 | 18 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 2193 | 0.020 |
Why?
|
| Protein Binding | 1 | 2015 | 1655 | 0.020 |
Why?
|
| Base Sequence | 1 | 2015 | 2734 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2020 | 5038 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 3469 | 0.020 |
Why?
|
| Logistic Models | 1 | 2015 | 1793 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 1484 | 0.020 |
Why?
|
| Software | 1 | 2015 | 731 | 0.020 |
Why?
|
| International Cooperation | 1 | 2010 | 160 | 0.020 |
Why?
|
| Reference Standards | 1 | 2010 | 232 | 0.020 |
Why?
|
| Europe | 1 | 2010 | 364 | 0.020 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2010 | 144 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2016 | 3357 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 2898 | 0.020 |
Why?
|
| Genome, Human | 1 | 2015 | 1314 | 0.020 |
Why?
|
| Adolescent | 2 | 2016 | 20716 | 0.020 |
Why?
|
| Maternal Age | 1 | 2007 | 133 | 0.020 |
Why?
|
| Research Design | 1 | 2010 | 715 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2016 | 6433 | 0.010 |
Why?
|
| Ambulatory Care Facilities | 1 | 2007 | 232 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2007 | 389 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 2599 | 0.010 |
Why?
|
| Hormone Antagonists | 1 | 2002 | 44 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2005 | 649 | 0.010 |
Why?
|
| Estradiol | 1 | 2005 | 461 | 0.010 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2002 | 38 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 1316 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2013 | 4671 | 0.010 |
Why?
|
| Middle Aged | 1 | 2014 | 28370 | 0.010 |
Why?
|